These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 25077968)

  • 41. Angiotensin-converting enzyme 2 attenuates the metastasis of non-small cell lung cancer through inhibition of epithelial-mesenchymal transition.
    Qian YR; Guo Y; Wan HY; Fan L; Feng Y; Ni L; Xiang Y; Li QY
    Oncol Rep; 2013 Jun; 29(6):2408-14. PubMed ID: 23545945
    [TBL] [Abstract][Full Text] [Related]  

  • 42. L1-mediated colon cancer cell metastasis does not require changes in EMT and cancer stem cell markers.
    Gavert N; Vivanti A; Hazin J; Brabletz T; Ben-Ze'ev A
    Mol Cancer Res; 2011 Jan; 9(1):14-24. PubMed ID: 21123622
    [TBL] [Abstract][Full Text] [Related]  

  • 43. AKT-ions with a TWIST between EMT and MET.
    Tang H; Massi D; Hemmings BA; Mandalà M; Hu Z; Wicki A; Xue G
    Oncotarget; 2016 Sep; 7(38):62767-62777. PubMed ID: 27623213
    [TBL] [Abstract][Full Text] [Related]  

  • 44. TGF-β orchestrates fibrogenic and developmental EMTs via the RAS effector RREB1.
    Su J; Morgani SM; David CJ; Wang Q; Er EE; Huang YH; Basnet H; Zou Y; Shu W; Soni RK; Hendrickson RC; Hadjantonakis AK; Massagué J
    Nature; 2020 Jan; 577(7791):566-571. PubMed ID: 31915377
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Functional cooperation between Snail1 and twist in the regulation of ZEB1 expression during epithelial to mesenchymal transition.
    Dave N; Guaita-Esteruelas S; Gutarra S; Frias À; Beltran M; Peiró S; de Herreros AG
    J Biol Chem; 2011 Apr; 286(14):12024-32. PubMed ID: 21317430
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Transformation of epithelial ovarian cancer stemlike cells into mesenchymal lineage via EMT results in cellular heterogeneity and supports tumor engraftment.
    Jiang H; Lin X; Liu Y; Gong W; Ma X; Yu Y; Xie Y; Sun X; Feng Y; Janzen V; Chen T
    Mol Med; 2012 Oct; 18(1):1197-208. PubMed ID: 22801793
    [TBL] [Abstract][Full Text] [Related]  

  • 47. ATF3, an adaptive-response gene, enhances TGF{beta} signaling and cancer-initiating cell features in breast cancer cells.
    Yin X; Wolford CC; Chang YS; McConoughey SJ; Ramsey SA; Aderem A; Hai T
    J Cell Sci; 2010 Oct; 123(Pt 20):3558-65. PubMed ID: 20930144
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Transforming growth factor-β-induced epithelial-mesenchymal transition facilitates epidermal growth factor-dependent breast cancer progression.
    Wendt MK; Smith JA; Schiemann WP
    Oncogene; 2010 Dec; 29(49):6485-98. PubMed ID: 20802523
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Membrane Type 1 Matrix Metalloproteinase induces an epithelial to mesenchymal transition and cancer stem cell-like properties in SCC9 cells.
    Yang CC; Zhu LF; Xu XH; Ning TY; Ye JH; Liu LK
    BMC Cancer; 2013 Apr; 13():171. PubMed ID: 23548172
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CSC-3436 inhibits TWIST-induced epithelial-mesenchymal transition via the suppression of Twist/Bmi1/Akt pathway in head and neck squamous cell carcinoma.
    Lai YJ; Yu WN; Kuo SC; Ho CT; Hung CM; Way TD; Chen CT
    J Cell Physiol; 2019 Jun; 234(6):9118-9129. PubMed ID: 30341909
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Transforming growth factor-beta as a key molecule triggering the expression of versican isoforms v0 and v1, hyaluronan synthase-2 and synthesis of hyaluronan in malignant osteosarcoma cells.
    Nikitovic D; Zafiropoulos A; Katonis P; Tsatsakis A; Theocharis AD; Karamanos NK; Tzanakakis GN
    IUBMB Life; 2006 Jan; 58(1):47-53. PubMed ID: 16540432
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hyperproduction of hyaluronan in neu-induced mammary tumor accelerates angiogenesis through stromal cell recruitment: possible involvement of versican/PG-M.
    Koyama H; Hibi T; Isogai Z; Yoneda M; Fujimori M; Amano J; Kawakubo M; Kannagi R; Kimata K; Taniguchi S; Itano N
    Am J Pathol; 2007 Mar; 170(3):1086-99. PubMed ID: 17322391
    [TBL] [Abstract][Full Text] [Related]  

  • 53. FOXO1 inhibits the invasion and metastasis of hepatocellular carcinoma by reversing ZEB2-induced epithelial-mesenchymal transition.
    Dong T; Zhang Y; Chen Y; Liu P; An T; Zhang J; Yang H; Zhu W; Yang X
    Oncotarget; 2017 Jan; 8(1):1703-1713. PubMed ID: 27924058
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes.
    Taube JH; Herschkowitz JI; Komurov K; Zhou AY; Gupta S; Yang J; Hartwell K; Onder TT; Gupta PB; Evans KW; Hollier BG; Ram PT; Lander ES; Rosen JM; Weinberg RA; Mani SA
    Proc Natl Acad Sci U S A; 2010 Aug; 107(35):15449-54. PubMed ID: 20713713
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Discovery of VEGFR-2 inhibitors exerting significant anticancer activity against CD44+ and CD133+ cancer stem cells (CSCs): Reversal of TGF-β induced epithelial-mesenchymal transition (EMT) in hepatocellular carcinoma.
    Modi SJ; Kulkarni VM
    Eur J Med Chem; 2020 Dec; 207():112851. PubMed ID: 33002846
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hyaluronan synthase HAS2 promotes tumor progression in bone by stimulating the interaction of breast cancer stem-like cells with macrophages and stromal cells.
    Okuda H; Kobayashi A; Xia B; Watabe M; Pai SK; Hirota S; Xing F; Liu W; Pandey PR; Fukuda K; Modur V; Ghosh A; Wilber A; Watabe K
    Cancer Res; 2012 Jan; 72(2):537-47. PubMed ID: 22113945
    [TBL] [Abstract][Full Text] [Related]  

  • 57. miR-300 inhibits epithelial to mesenchymal transition and metastasis by targeting Twist in human epithelial cancer.
    Yu J; Xie F; Bao X; Chen W; Xu Q
    Mol Cancer; 2014 May; 13():121. PubMed ID: 24885626
    [TBL] [Abstract][Full Text] [Related]  

  • 58. TWIST1-mediated transcriptional activation of PDGFRβ in breast cancer stem cells promotes tumorigenesis and metastasis.
    Yeeravalli R; Kaushik K; Das A
    Biochim Biophys Acta Mol Basis Dis; 2021 Jul; 1867(7):166141. PubMed ID: 33845139
    [TBL] [Abstract][Full Text] [Related]  

  • 59. SNAIL regulates interleukin-8 expression, stem cell-like activity, and tumorigenicity of human colorectal carcinoma cells.
    Hwang WL; Yang MH; Tsai ML; Lan HY; Su SH; Chang SC; Teng HW; Yang SH; Lan YT; Chiou SH; Wang HW
    Gastroenterology; 2011 Jul; 141(1):279-91, 291.e1-5. PubMed ID: 21640118
    [TBL] [Abstract][Full Text] [Related]  

  • 60. SLUG/SNAI2 and tumor necrosis factor generate breast cells with CD44+/CD24- phenotype.
    Bhat-Nakshatri P; Appaiah H; Ballas C; Pick-Franke P; Goulet R; Badve S; Srour EF; Nakshatri H
    BMC Cancer; 2010 Aug; 10():411. PubMed ID: 20691079
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.